NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 32 filers reported holding NRX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,702 | -46.2% | 114,240 | 0.0% | 0.00% | – |
| Q2 2023 | $55,235 | -26.6% | 114,240 | 0.0% | 0.00% | – |
| Q1 2023 | $75,296 | -70.3% | 114,240 | -50.0% | 0.00% | – |
| Q4 2022 | $253,612 | +198.4% | 228,480 | +100.0% | 0.00% | – |
| Q3 2022 | $85,000 | +23.2% | 114,240 | 0.0% | 0.00% | – |
| Q2 2022 | $69,000 | -75.4% | 114,240 | 0.0% | 0.00% | – |
| Q1 2022 | $280,000 | +471.4% | 114,240 | +1009.1% | 0.00% | – |
| Q4 2021 | $49,000 | – | 10,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Texas Capital Bank Wealth Management Services Inc | 63,290 | $41,714 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 230,700 | $152,054 | 0.00% |
| Virtu Financial LLC | 46,210 | $30 | 0.00% |
| United Asset Strategies, Inc. | 18,300 | $12,062 | 0.00% |
| HBK Sorce Advisory LLC | 29,230 | $19,266 | 0.00% |
| UBS Group AG | 18,611 | $12,265 | 0.00% |
| NewEdge Advisors, LLC | 2,125 | $1,401 | 0.00% |
| OSAIC HOLDINGS, INC. | 27,225 | $17,933 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 30,000 | $19,770 | 0.00% |
| WELLS FARGO & COMPANY/MN | 5,309 | $3,500 | 0.00% |